Study: Early MRI Screening Reduces Breast Cancer Mortality Among Female Hodgkin’s Lymphoma Survivors

Study: Early MRI Screening Reduces Breast Cancer Mortality Among Female Hodgkin’s Lymphoma Survivors
Researchers at Princess Margaret Cancer Centre in Toronto, Canada, found that early MRI-based screening reduces breast cancer mortality among women survivors of childhood Hodgkin's lymphoma (HL) who were treated with thoracic radiation therapy. The study, titled “Impact of Early Breast Cancer Screening on Mortality Among Young Survivors of Childhood Hodgkin’s Lymphoma,” was published in the Journal of the National Cancer Institute. Survivors of childhood cancers are at increased risk for delayed morbidity related to their treatment, and more effort is being directed at preventing or ameliorating late-treatment toxicity. One potentially modifiable late effect is mortality as a consequence of breast cancer among women treated with thoracic radiation therapy. Particularly, adolescent females treated with thoracic radiation therapy for HL have been shown to have a statistically significantly elevated risk of developing breast cancer, and consensus guidelines recommend the early initiation of breast cancer screening among these survivors. Earlier work among researchers at the Princess Margaret Cancer Centre had shown that MRI detects breast cancer at early stages in young survivors who are not old enough to start standard breast cancer screening. "If you are a young woman who was treated with radiation therapy to your chest as a teenager o
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.